GNANI, ALESSANDRA
GNANI, ALESSANDRA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Collaboratori
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients
2014 Annalisa Lonetti, Ilaria Iacobucci, Anna Ferrari, Monica Messina, Daniela Cilloni, Simona Soverini, Sabina Chiaretti, Emanuela Ottaviani, Nicoletta Testoni, Cristina Papayannidis, Francesca Messa, Federica Salmi, Antonella Vitale, Francesca Arruga, Fabrizio Pane, Pier Paolo Piccaluga, Alessandra Gnani, Stefania Paolini, Carla De Giovanni, Giuseppe Saglio, Michele Baccarani, Robin Foà, Giovanni Martinelli
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology
2012 Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Cattina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G
Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience
2010 Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandra; Lonetti, Annalisa; Ferrari, Anna; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Clissa, Cristina; Parisi, Sarah; Guadagnuolo, Viviana; Baccarani, Michele; Martinelli, Giovanni
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience
2009 Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandra; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Abbenante, Mariachiara; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Piccaluga, PIER PAOLO; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib
2008 Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papayannidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M.
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia
2006 Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML)
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients | Annalisa Lonetti, Ilaria Iacobucci, Anna Ferrari, Monica Messina, Daniela Cilloni, Simona Soverin...i, Sabina Chiaretti, Emanuela Ottaviani, Nicoletta Testoni, Cristina Papayannidis, Francesca Messa, Federica Salmi, Antonella Vitale, Francesca Arruga, Fabrizio Pane, Pier Paolo Piccaluga, Alessandra Gnani, Stefania Paolini, Carla De Giovanni, Giuseppe Saglio, Michele Baccarani, Robin Foà, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology | Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Ca...ttina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G | 2012-01-01 | CANCER RESEARCH | American Association of Cancer Research | 4.02 Riassunto (Abstract) | - |
| Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience | Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandr...a; Lonetti, Annalisa; Ferrari, Anna; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Clissa, Cristina; Parisi, Sarah; Guadagnuolo, Viviana; Baccarani, Michele; Martinelli, Giovanni | 2010-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience | Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandr...a; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Abbenante, Mariachiara; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Piccaluga, PIER PAOLO; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni | 2009-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib | Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papaya...nnidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 4.01 Contributo in Atti di convegno | - |
| Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia | Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruz...zese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML) | 2006-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |